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METHOD AND DEVICE FOR REMOVAL OF 
CRYOPROTECTANT FROM 
CRYOPRESERVED BIOLOGICAL CELLS 
AND TISSUES 
This application claims the bene?t of US. Provisional 
Patent Application Ser. No. 60/307,989, ?led Jul. 26, 2001. 
This invention Was made With partial Government sup 
port under NSF grant no. DMI-9901698. The Government 
may have certain rights in this invention. 
TECHNICAL FIELD 
The present invention relates to methods for removal of 
cryoprotectant from suspensions of cryopreserved biological 
cells and tissues following thaWing. The invention more 
speci?cally relates to a perfusion-Washing method and 
device for removal of cryoprotectant from cryopreserved 
biological cells and tissues folloWing thaWing. 
BACKGROUND OF THE INVENTION 
It is knoWn to utiliZe various cryoprotectants, such as for 
example dimethyl sulfoxide, during cryopreservation of 
cells. Use of a cryoprotectant is essential to prevent cryoin 
jury from, e.g., formation of intracellular ice crystals during 
freezing. HoWever, at room and/or body temperature, certain 
cryoprotectants such as DMSO are knoWn to be toxic to 
cells. Accordingly, cryoprotectant must be removed from 
cryopreserved cell cultures as soon as possible after thaWing 
to prevent cellular damage. 
The most common method for removal of cryoprotectant 
from cryopreserved cells is by mechanical removal, i.e. 
centrifugation folloWed by resuspension in the media of 
choice to remove the cryoprotectant by dilution. HoWever, 
the mechanical forces introduced during centrifugation 
result in osmotic stress and cell clumping/lysing, particu 
larly if the cell of choice is fragile. The generally open nature 
of most centrifugation processes may also result in bacterial 
or viral contamination of cell preparations. Accordingly, 
there is need in the art for a method of removing cryopro 
tectant Which does not result in cell damage or risk con 
tamination of cell preparations. The instant invention satis 
?es this need by providing a method and device for 
removing cryoprotectant using a counter-current perfusion 
Washing system. 
SUMMARY OF THE INVENTION 
In accordance With the purposes of the present invention 
as described herein, in one aspect of the present invention a 
method is provided for removing a cryoprotectant from an 
interior of a cell immersed in a cryoprotectant-containing 
liquid, comprising the steps of passing the cryoprotectant 
containing liquid through at least one semipermeable holloW 
?ber membrane contained in a holloW module in a ?rst 
direction to contact said holloW ?ber membrane on at least 
one interior surface. Concurrently, a liquid Which is sub 
stantially free of cryoprotectant is passed through the holloW 
module in a second direction (opposite to the ?rst direction) 
so that the cryoprotectant-free liquid contacts the semiper 
meable holloW ?ber membrane on at least one exterior 
surface. It Will be appreciated that a diffusion gradient is 
created, thereby transferring the cryoprotectant from the 
cryoprotectant-containing liquid to the cryoprotectant-free 
liquid for removal. 
The method of the present invention is suitable for use on 
cryopreserved cells contained in suspension. Similarly, the 
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method is suitable for cryopreserved tissue blocks, for 
monolayer cell cultures, and for so-called “bioreactors”, 
Wherein the cells of interest are seeded in a substantially 
solid groWth matrix for groWth prior to immersion in the 
cryoprotectant-containing liquid. It Will be appreciated that 
cells in suspension in cryoprotectant-containing liquid may 
be directly passed through the semipermeable holloW ?ber 
membrane of the present invention. For cells groWn in or on 
solid matrices, such as tissue blocks or bioreactors in a cell 
culture dish, cryoprotectant-containing liquid cell culture 
media may be removed from the cell culture dish, passed 
though the semipermeable holloW ?ber membranes as 
described to remove cryoprotectant, and returned to the cell 
culture dish. 
Any semipermeable holloW ?ber membrane capable of 
alloWing passage of a cryoprotectant therethrough While 
preventing passage of cells is suitable for the method of this 
invention. In one presently preferred embodiment, a semi 
permeable holloW ?ber membrane having a porosity of from 
about 50% to about 80% is used. Typically, a semipermeable 
holloW ?ber membrane having a porosity of about 70% is 
used. 
In accomplishing the method of the present invention, a 
?rst ?oW rate for passing cryoprotectant-containing liquid 
through the interior of the semipermeable holloW ?ber 
membrane is selected to be sufficient to alloW diffusion of 
the cryoprotectant from the interior of the membrane to the 
exterior. The second ?oW rate for removing cryoprotectant 
from the exterior surface of the membrane is selected to be 
suf?cient to alloW removal of cryoprotectant from the exte 
rior surface of the membrane to prevent fouling of the 
exterior of the membrane ?ber. 
In another aspect, a method for removing a cryoprotectant 
from an interior of a cell immersed in a cryoprotectant 
containing liquid is provided. The method comprises the 
steps of: (1) determining the membrane transfer potential of 
a chosen semipermeable holloW ?ber membrane material for 
a cryoprotectant of choice; (2) calculating a ?rst ?oW rate 
based on the membrane transfer potential for passing the 
cryoprotectant-containing liquid through the semipermeable 
holloW ?ber membrane; (3) calculating a second ?oW rate 
based on the membrane transfer potential for passing a 
cryoprotectant-free liquid through the holloW module; (4) 
passing the cryoprotectant-containing liquid through at least 
one semipermeable holloW ?ber membrane contained Within 
the holloW module at the calculated ?rst ?oW rate in a ?rst 
direction to contact the holloW ?ber membrane on at least 
one interior surface; (5) passing the cryoprotectant-free 
liquid at the second ?oW rate through the holloW module in 
a second direction opposite to the ?rst direction so that the 
cryoprotectant-free liquid contacts the semipermeable hol 
loW ?ber on at least one exterior surface; and (5) transferring 
cryoprotectant from the cryoprotectant-containing liquid to 
the cryoprotectant-free liquid across a diffusion gradient 
created betWeen the interior surface and the exterior surface 
of the semipermeable holloW ?ber. 
It Will be appreciated that the membrane transfer potential 
of a particular material from Which the semipermeable 
holloW ?ber is fabricated is knoWn for many suitable 
materials, or may be determined by experimentation. As 
noted above, the method is suitable for removing cryopro 
tectant from cells any state, such as in suspension, in tissue 
blocks, in monolayer culture, and seeded in bioreactors. The 
characteristics of the semipermeable holloW ?ber mem 
branes and the desired ?rst and second ?oW rates are as 
described above. 
In accomplishing the methods of the present invention, 
the ?rst and second ?oW rate Will be calculated in accor 
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dance With the membrane transfer potential of the semiper 
meable hollow ?ber membrane for the cryoprotectant of 
choice. Thus, it Will be appreciated that the method of this 
invention may be tailored speci?cally to optimal removal of 
a particular cryoprotectant from a particular cell culture 
media. 
In yet another aspect of this invention, a device for 
removing cryoprotectant from an interior of a cell immersed 
in a cryoprotectant-containing liquid is provided, compris 
ing a holloW module, at least one semipermeable holloW 
?ber membrane contained Within an interior of the holloW 
module, a means for passing the cryoprotectant-containing 
liquid through the semipermeable holloW ?ber membrane in 
a ?rst direction, and a means for passing a substantially 
cryoprotectant-free liquid through the exterior holloW mod 
ule in a second direction opposite to the ?rst direction. The 
device is suitable for removing cryoprotectant from cells in 
any state, such as in suspension, in tissue blocks, in mono 
layer culture, and seeded in bioreactors. The characteristics 
of the semipermeable holloW ?ber membranes and the 
desired ?rst and second ?oW rates are as described above. 
Any suitable means may be employed for passing liquid 
through the semipermeable holloW ?ber membrane and the 
holloW module may be used, such as a peristaltic pump, a 
syringe pump, or the like. The device may comprise a closed 
system, Wherein cells in cryoprotectant-containing liquid are 
recirculated through the semipermeable holloW ?ber mem 
brane and cryoprotectant-free liquid is recirculated through 
the holloW module, or may be an open system Wherein only 
a single passage of cells/cryoprotectant-containing liquid 
and cryoprotectant-free liquid are used. 
Other objects and applications of the present invention 
Will become apparent to those skilled in this art from the 
folloWing description Wherein there is shoWn and described 
a preferred embodiment of this invention, simply by Way of 
illustration of the modes currently best suited to carry out the 
invention. As it Will be realiZed, the invention is capable of 
other different embodiments and its several details are 
capable of modi?cation in various, obvious aspects all 
Without departing from the invention. Accordingly, the 
draWings and descriptions Will be regarded as illustrative in 
nature and not as restrictive. 
BRIEF DESCRIPTION OF THE DRAWING 
The accompanying draWing incorporated in and forming 
a part of the speci?cation illustrates several aspects of the 
present invention and, together With the description, serves 
to explain the principles of the invention. In the draWing: 
FIG. 1 shoWs a schematic representation of the device of 
the present invention, With the semipermeable holloW ?ber 
membranes shoWn schematically in the interior of the hol 
loW module in cross-section. 
FIG. 2 shoWs changes in osmolality of cord blood With 
DMSO and in cryoprotectant-free perfusion solution, and 
percent clearance of DMSO from cord blood as a function 
of time of Washing. 
FIG. 3 shoWs a schematic representation of the calcula 
tions performed by the softWare program of the present 
invention. 
Reference Will noW be made in detail to a presently 
preferred embodiment of the invention, examples of Which 
are illustrated in the accompanying draWing. 
DETAILED DESCRIPTION OF THE 
INVENTION 
As shoWn schematically in FIG. 1, the method of the 
present invention comprises passage of a cryoprotectant 
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containing liquid in a ?rst direction through holloW, semi 
porous membrane ?bers contained in a holloW module in 
such a Way as to contact an internal surface of the ?bers. 
Suitable holloW, semi-permeable ?bers and cylindrical mod 
ules are knoWn in the art, particularly in the dialysis arts. 
Cryoprotectant-free liquid is passed through the holloW 
module in a second direction, opposite to the ?rst direction, 
in such a Way as to contact an external surface of the ?bers. 
The device 10 of the invention comprises a holloW module 
20 having a ?rst inlet 22 and a ?rst outlet 24 for 
cryoprotectant-containing liquid, and a second inlet 26 and 
a second outlet 28 for cryoprotectant-free liquid. As shoWn 
in partial cross-section, the holloW module 20 includes a 
plurality of semipermeable holloW ?ber membranes 30, each 
having a lumen 32. Cryoprotectant-containing liquid is 
passed through inlet 22, through the lumens 32 of each 
membrane 30, and out outlet 24. Concurrently, 
cryoprotectant-free liquid is passed into holloW module 20 
through inlet 26, through a space 34, contacting the exterior 
of holloW ?ber membranes 30, and out outlet 28. Any 
suitable means, such as syringe pumps or peristaltic pumps 
(not shoWn) may be used to effect ?uid ?oW through the 
device of the invention. 
It Will be appreciated that, by selection of appropriate 
holloW, semipermeable ?bers, a diffusion gradient is estab 
lished Whereby cryopreservant ?oWs from the 
cryoprotectant-containing liquid (containing a relatively 
high concentration of cryoprotectant) to the cryoprotectant 
free liquid (containing a relatively loW concentration of 
cryoprotectant). When this counter-?oW perfusion technique 
is used, cryopreservant diffuses from the cyoprotectant 
containing liquid contained in the inner portion of the 
holloW ?bers into the cryoprotectant-free liquid. In a closed 
system, the cryoprotectant-containing liquid may be recir 
culated through the holloW, semipermeable membrane ?bers 
until the desired amount of cryopreservant is removed. It 
Will be appreciated that the cryoprotectant-free liquid may 
be supplied in either a closed or an open system (comprising 
discarding cryoprotectant-free liquid after a single passage 
through the holloW module). 
EXAMPLE 1 
In accordance With the methods of the invention, a 
cylindrical module as described above Was loaded With 500 
cellulose-triacetate ?bers (internal diameter 100 pm; mem 
brane thickness 15 pm; porosity 70%). Hematopoietic pro 
genitor cells (HPCs) derived from umbilical cord blood and 
cryopreserved in a solution containing 10% DMSO, Were 
passed through the cellulose-triacetate ?bers in a ?rst direc 
tion. Isotonic perfusion media (substantially free of 
cryoprotectant) Was passed through the cylindrical module 
in a second direction, directly opposite to the ?rst direction, 
in such a Way as to contact the outer surface of the ?bers. 
The cell suspension Was recirculated through the ?bers by 
automated pumps in a closed system until over 95% of the 
original concentration of DMSO Was removed. 
As best seen in FIG. 2, on the basis of calculated changes 
in total osmolality, percent DMSO clearance, and change in 
osmolality of the perfusion Washing medium, over 95% of 
the DMSO in the cryopreserved blood sample Was removed 
by the method and device of the instant invention Within 5 
minutes of initiation of the Washing process. No cell clump 
ing Was observed. 
EXAMPLE 2 
Fresh umbilical cord blood samples Were mixed With 
cryoprotectant solution (20% DMSO v/v, 10% citrate 
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phosphate double dextrose [CP2D] v/v, and 70% phosphate 
buffered saline v/v) in a 1:1 ratio (?nal concentration of 
DMSO=10% v/v). The umbilical cord blood samples Were 
then cooled and cryopreserved. After 1 Week storage in 
liquid nitrogen, the cells Were thaWed. Samples of the blood 
Were subjected to standard centrifugation/Washing tech 
niques and to the novel perfusion Washing method of the 
present invention as described in Example 1 supra. 
As best seen in Table 1, cell function survival Was 
signi?cantly enhanced in cell preparations subjected to the 
method of the present invention (compared to standard 
centrifugation Washing) for removal of DMSO. FloW cytom 
etry studies (not shoWn) conducted using methods knoWn in 
the art shoWed that recovery of CD34+cells Was 92% for the 
method of this invention, in comparison to 80% recovery of 
CD34+cells for centrifugation Washing. 
TABLE 1 
Cell function survival (%, in comparison With the fresh control) With 
different cell Washing approaches (centrifugation vs. dialysis N = 8) 
CFU-E BFU-E CFU-GM 
Centrifuge 11.3 r 4.1% 27.3 r 2.2% 49.3 r 5.1% 
Dialysis 45.0 r 3.2% 47.9 r 7.3% 72.5 r 4.5% 
Accordingly, the method and device of the present inven 
tion provides a reliable, effective means for removing cryo 
protectant from cell suspensions Which signi?cantly reduces 
cell clumping, cell lysis, loss in viability, and osmotic injury. 
The method is suitable for removal of cryoprotectant of 
numerous useful cell types, including bone marroW/cord 
blood hematopoietic progenitor cells for cancer treatment 
and gene therapy, for tissue cryopreservation for 
transplantation, for sperm/oocyte preservation for arti?cial 
insemination and in vitro fertiliZation, for cryopreservation 
of cell lines for research, and the like. 
It Will be appreciated that the method and device of this 
invention is equally suited to removal of cryoprotectant from 
cells cryopreserved other than in suspension. For example, 
it is knoWn to culture and cryopreserve cells by seeding in 
“bioreactors” comprising a porous groWth matrix such as 
polyglycolic acid polymers, polylactic acid polymers, 
collagen, and the like. The method of the present invention 
may easily be adapted for such cultures by simply extracting 
the cryoprotectant-containing media bathing the porous 
groWth matrix in the cell culture vessel, passing it through 
the semipermeable holloW ?ber membranes of the invention, 
and returning the media, noW free of cryoprotectant, to the 
cell culture vessel. 
In still another aspect of the present invention, a method 
for determining optimum operating conditions of the device 
of the present invention for removal of cryoprotectant is 
provided. It has been discovered that the ?rst, cell/ 
cryoprotectant liquid ?oW rate may be accurately predicted 
using Navier-Stokes equations. FloW rate of the second, 
cryoprotectant-free liquid may be accurately predicted using 
Darcy equations. Permeating ?oW through the 
semipermiable, holloW ?ber membrane for a particular cryo 
protectant may be accurately predicted using Kedem 
Katchalsky equations. 
Darcy’s laW describes the relationship betWeen volume 
average velocity and gradient of volume average pressure: 
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pkrrm '41 = 
Where Krr and KZZ are Darcy permeability in r and Z 
direction respectively. 
The volume average conservation of mass equation is: 
16074,) 6141 _ S (2) 
Inserting eq.(1) into eq.(2), gives: 
(3) 
If K K22 and p are constant, eq.(3) can be simpli?ed as: 
Considering a ?uid control volume, Whose cross section 
area is A and length is AZ. The number of holloW ?bers NH 
may be estimated in this control volume by 
(5) 
Where AH is the cross sectional area of one holloW ?ber, 
and f is packing density. Then membrane area Am in 
this control volume can be determined by 
Am=NHndH-Az (6) 
Where dH is the diameter of holloW ?ber. 
Therefore, Sm may be calculated by 
(7) 
Where J v is the ultra?ltration rate, Which can be calculated 
by Kedem-Katchalsky equation (K—K equation): 
JV=L[,-Ap—oL[,RT-AC (8) 
Where Ap is the difference of pressure betWeen 
cryoprotectant-containing liquid and cryoprotectant 
free liquid, Ac is the difference of concentration 
betWeen cryoprotectant-containing liquid and 
cryoprotectant-free liquid, LP is the hydraulic perme 
ability of membrane, 0 is re?ection coef?cient, T is 
temperature, and R is universal gas constant. 
Neglecting mass transfer by shell-side diffusion or Taylor 
dispersion relative to convection, the equation of concen 
tration can be Written as: 
Where C is the cryoprotectant concentration, and SS is the 
cryoprotectant source. The cryoprotectant concentra 
tion in the cryoprotectantfree liquid increases from inlet 
to outlet, While cryoprotectant concentration in 
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cryoprotectant-containing liquid decreases from 
sample inlet to outlet. 
SS can be estimated by 
Where J5 is solute ?ux across the membrane. K—K equation 
can be used to calculate J5: 
JS=CS'(1—o)IV+PS-ACS (10) 
Where c; is average of solute concentration inside 
membrane, P5 is solute diffusive permeability of mem 
brane. 
In a typical con?guration of the device of the present 
invention, a bundle of semipermeable holloW ?ber mem 
branes is contained in a holloW module and encapsulated at 
each end forming tubesheets. At each end, a gasket and 
endcap form headers to direct sample How in and out of the 
lumens of the ?bers. Accordingly, the sample How is more 
uniform than cryoprotectant-free liquid ?oW. In our model, 
the How rate in the inlet of each ?ber membrane is assumed 
to be the same. Using Navier-Stokes equations to simulate 
the sample ?oW: 
Continuity Equation: 
V-u=0 (11) 
Momentum Equations: 
1 6 l2 14-Vu,=———p+?V2u, ( ) 
P W p 
l 6 l3 u-V --_p + 5V2 ( ) 
p 61 p 
Concentration Equation: 
Where u is the velocity vector: u=(U,, uZ). 
It Will therefore be appreciated that, using the calculations 
as described above, it is possible using knoWn permeation 
rates of particular cryoprotectants through speci?c semiper 
meable holloW ?ber membranes to design devices in accor 
dance With the present invention With optimal sample (cell 
plus cryoprotectant-containing liquid) and cryoprotectant 
free liquid ?oW rates for removal of cryoprotectant from the 
cryoprotectant-containing liquid, and thereby from the cell 
of choice. Accordingly, in yet another aspect of the present 
invention, a softWare program is provided alloWing simula 
tion of mass transport through the device of this invention. 
The softWare predicts optimal ?oW rates for removal of 
particular cryoprotectants using semipermeable holloW ?ber 
membranes constructed of materials of knoWn properties. 
Accordingly, as shoWn in FIG. 3, the softWare program of 
the present invention alloWs prediction of suitable ?oW rates 
as described above for cryoprotectant removal for any 
combination of cryoprotectant and holloW ?ber material. 
Thus, the user is able to determine the optimal ?oW rate of 
cryoprotectant-containing liquid and cryoprotectant-free liq 
uid for removal of cryoprotectant in the most ef?cient 
manner. 
The foregoing description of a preferred embodiment of 
the invention has been presented for purposes of illustration 
and description. It is not intended to be exhaustive or to limit 
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the invention to the precise form disclosed. Obvious modi 
?cations or variations are possible in light of the above 
teachings. The embodiment Was chosen and described to 
provide the best illustration of the principles of the invention 
and its practical application to thereby enable one of ordi 
nary skill in the art to utiliZe the invention in various 
embodiments and With various modi?cations as are suited to 
the particular use contemplated. All such modi?cations and 
variations are Within the scope of the invention as deter 
mined by the appended claims When interpreted in accor 
dance With the breadth to Which they are fairly, legally and 
equitably entitled. 
What is claimed is: 
1. A method for removing a cryoprotectant from an 
interior of a cell immersed in a cryoprotectant-containing 
liquid, comprising the steps of: 
passing the cryoprotectant-containing liquid through at 
least one semipermeable holloW ?ber membrane con 
tained in a holloW module in a ?rst direction to contact 
said holloW ?ber membrane on at least one interior 
surface; 
passing a liquid Which is substantially free of cryopro 
tectant through said holloW module in a second direc 
tion opposite to said ?rst direction so that said 
cryoprotectant-free liquid contacts said semipermeable 
holloW ?ber membrane on at least one exterior surface; 
and 
transferring said cryoprotectant from said cryoprotectant 
containing liquid to said cryoprotectant-free liquid 
across a diffusion gradient betWeen said interior surface 
and said exterior surface of said semipermeable holloW 
?ber membrane. 
2. The method of claim 1, Wherein said cell is contained 
in said cryoprotectant-containing liquid in a suspension. 
3. The method of claim 1, Wherein said cell is a tissue 
block immersed in said cryoprotectant-containing liquid. 
4. The method of claim 1, Wherein said cell is seeded in 
a porous groWth matrix immersed in said cryoprotectant 
containing liquid. 
5. The method of claim 1, Wherein said cell is groWn in 
a monolayer on a surface matrix immersed in said 
cryoprotectant-containing liquid. 
6. The method of claim 2, Wherein said semipermeable 
holloW ?ber membrane has a porosity of from about 50% to 
about 80%. 
7. The method of claim 2, Wherein said semipermeable 
holloW ?ber membrane has a porosity of about 70%. 
8. The method of claim 1, Wherein said ?rst ?oW rate is 
suf?cient to alloW transfer of cryoprotectant contained in 
said cryoprotectant-containing liquid from said interior sur 
face of said semipermeable holloW ?ber membrane to said 
exterior surface of said semipermeable holloW ?ber mem 
brane. 
9. The method of claim 1, Wherein said second ?oW rate 
is sufficient to substantially prevent retention of cryopro 
tectant on said exterior surface of said semipermeable hol 
loW ?ber membrane. 
10. A method for removing a cryoprotectant from an 
interior of a cell immersed in a cryoprotectant-containing 
liquid, comprising the steps of: 
determining a membrane transfer potential of a semiper 
meable holloW ?ber membrane for said cryoprotectant; 
calculating a ?rst ?oW rate based on said membrane 
transfer potential for passing the cryoprotectant 
containing liquid through said semipermeable holloW 
?ber membrane to remove said cryoprotectant from 
said cryoprotectant-containing liquid; 
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calculating a second ?oW rate based on said membrane 
transfer potential for passing a cryoprotectant-free liq 
uid through said hollow module; 
passing the cryoprotectant-containing liquid through at 
least one said semipermeable holloW ?ber membrane 
contained Within the holloW module at said ?rst ?oW 
rate in a ?rst direction to contact said holloW ?ber 
membrane on at least one interior surface; 
passing the cryoprotectant-free liquid at said second ?oW 
rate through the holloW module in a second direction 
opposite to said ?rst direction so that said 
cryoprotectant-free liquid contacts said semipermeable 
holloW ?ber on at least one exterior surface; and 
transferring said cryoprotectant from said cryoprotectant 
containing liquid to said cryoprotectant-free liquid 
across a diffusion gradient created betWeen said interior 
surface and said exterior surface of said semipermeable 
holloW ?ber. 
11. The method of claim 10, Wherein said cell is contained 
in said cryoprotectant-containing liquid in suspension. 
12. The method of claim 10, Wherein said cell is contained 
in a tissue block immersed in said cryoprotectant-containing 
liquid. 
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13. The method of claim 10, Wherein said cell is contained 
in a porous groWth matrix immersed in said cryoprotectant 
containing liquid. 
14. The method of claim 10, Wherein said cell is groWn in 
monolayer culture on a solid matrix prior to immersion in 
said cryoprotectant-containing liquid. 
15. The method of claim 10, Wherein said porous holloW 
?ber membrane has a porosity of from about 50% to about 
80%. 
16. The method of claim 10, Wherein said porous holloW 
?ber membrane has a porosity of about 70%. 
17. The method of claim 1, Wherein said ?rst ?oW rate is 
suf?cient to alloW transfer of cryoprotectant contained in 
said cryoprotectant-containing liquid from said interior sur 
face of said semipermeable holloW ?ber membrane to said 
exterior surface of said semipermeable holloW ?ber mem 
brane. 
18. The method of claim 1, Wherein said second ?oW rate 
is sufficient to substantially prevent retention of cryopro 
tectant on said exterior surface of said semipermeable hol 
loW ?ber membrane. 
